MATHEMATICAL FORMULAS FOR THE PREDICTION OF THE RESIDUAL BETA-CELL FUNCTION DURING THE FIRST 2 YEARS OF DISEASE IN CHILDREN AND ADOLESCENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS

被引:208
作者
KLIPPERAURBACH, Y
WASSERMAN, M
BRAUNSPIEGELWEINTROB, N
BORSTEIN, D
PELEG, S
ASSA, S
KARP, M
BENJAMINI, Y
HOCHBERG, Y
LARON, Z
机构
[1] CHILDRENS MED CTR,WHO COLLABORATING CTR STUDY DIABET YOUTH,INST PEDIAT & ADOLESCENT ENDOCRINOL,IL-49100 PETAH TIQWA,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,FAC MATH,IL-69978 TEL AVIV,ISRAEL
关键词
D O I
10.1016/0306-9877(95)90228-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
On the basis of a retrospective study of 71 children followed for 24 months after diagnosis of type I insulin dependent diabetes a fitted mathematical model was constructed for the prediction of the course of beta cell function from the time of diagnosis. Two equations were derived, one for the maximal basal (B-max) and the other for the maximal i.v. glucagon stimulated peak C-peptide (P-max) levels reached during the remission period. The prognostic variables selected for analysis were: peak C-peptide levels at diagnosis (Po), age, sex, degree of obesity, pubertal rating, the presence of islet cell antibodies (ICA) and levels of GHb. Multivariate analysis of the data showed that Po (p = 0.0006), puberty (p = 0.041), obesity (p = 0.0021), sex (p = 0.031), ICA (p = 0.0045) and GHb (p = 0.0066) significantly contributed to the prediction formula obtained for B-max whereas the contribution of the above variables for P-max were: Po (p = 0.0019), puberty (p = 0.0187), obesity (p = 0.0058), sex (p = 0.0598), ICA (p = 0.0187) and GHb (p = 0.0027). The residuals of the observed values from the values fitted by the predicted equations served to define two separate groups demonstrating distinct differences in the natural course of beta cell function in type I diabetes. This fitted model may thus be useful in distinguishing between newly diagnosed young patients who will undergo remission, requiring lower insulin doses, and those who have little chance for remission. It might also be helpful in the selection of patients most likely to benefit from immunosuppression or modulation, to maximize the benefit to risk ratio for such patients.
引用
收藏
页码:486 / 490
页数:5
相关论文
共 22 条
[1]   IMPROVED DIABETIC CONTROL IN A DISTRICT GENERAL-HOSPITAL CLINIC [J].
ALLGROVE, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (02) :180-185
[2]   ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[3]   FACTORS ASSOCIATED WITH EARLY REMISSION OF TYPE-I DIABETES IN CHILDREN TREATED WITH CYCLOSPORINE [J].
BOUGNERES, PF ;
CAREL, JC ;
CASTANO, L ;
BOITARD, C ;
GARDIN, JP ;
LANDAIS, P ;
HORS, J ;
MIHATSCH, MJ ;
PAILLARD, M ;
CHAUSSAIN, JL ;
BACH, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (11) :663-670
[4]  
BRUINING GJ, 1984, DIABETOLOGIA, V26, P24
[5]   RESIDUAL BETA-CELL FUNCTION AND ISLET CELL ANTIBODIES IN DIABETIC CHILDREN [J].
CROSSLEY, JR ;
JAMES, AG ;
ELLIOTT, RB ;
BERRYMAN, CC ;
EDGAR, BW .
PEDIATRIC RESEARCH, 1981, 15 (01) :62-65
[6]  
EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
[7]   TRIAD OF MARKERS FOR IDENTIFYING CHILDREN AT HIGH-RISK OF DEVELOPING INSULIN-DEPENDENT DIABETES-MELLITUS [J].
GINSBERGFELLNER, F ;
WITT, ME ;
FRANKLIN, BH ;
YAGIHASHI, S ;
TOGUCHI, Y ;
DOBERSEN, MJ ;
RUBINSTEIN, P ;
NOTKINS, AL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (11) :1469-1472
[8]  
GORSUCH AN, 1981, LANCET, V2, P1363
[9]   RADIOIMMUNOLOGICAL DETERMINATION OF HUMAN C-PEPTIDE IN SERUM [J].
HEDING, LG .
DIABETOLOGIA, 1975, 11 (06) :541-548
[10]   MEAL-STIMULATED C-PEPTIDE AND INSULIN-ANTIBODIES IN TYPE-I DIABETIC SUBJECTS AND THEIR NONDIABETIC SIBLINGS CHARACTERIZED BY HLA-DR ANTIGENS [J].
HOOGWERF, BJ ;
RICH, SS ;
BARBOSA, JJ .
DIABETES, 1985, 34 (05) :440-445